Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2/PHASE3
32 participants
INTERVENTIONAL
2007-09-30
2008-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Green Tea Extract on Type 2 Diabetes With Hyperlipidemia
NCT01360567
Clinical Study to Evaluate the Effects and Safety of Green Tea Extract on Blood Glucose Regulation
NCT06592365
Effect of an Extract of Green Tea on Adults With Type 2 Diabetes
NCT00389350
Effect of Green Tea Extract on Lipids in Patients With Type 2 Diabetes
NCT04532385
Effect of Green Tea Extract on Arterial Stiffness in Type 2 Diabetes Mellitus
NCT02627898
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The benefit effects of green tea are mainly attributed to its polyphenol content, especially the most abundant one-epigallocatechin gallate (EGCG), which might inhibit adipocyte proliferation and differentiation in vitro studies
We hypothesized that GTE would improve insulin resistance in type 2 overweight diabetes and related hormone peptides will be influenced. Thus, we conducted this randomized clinical trial to examine the effect of GTE on type 2 diabetes and to explore the relationship between GTE and related hormone peptides.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A
Green tea extract
Green tea extract
main content is epigallocatechin gallate (EGCG, 58%)
B
Green tea extract
main content is epigallocatechin gallate (EGCG, 58%)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Green tea extract
main content is epigallocatechin gallate (EGCG, 58%)
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Body mass index \>25 kg/mm
* Aged between 20 and 65 years
* Being Chinese
Exclusion Criteria
* Prolating or pregnant women, and patients with heart failure, acute myocardiac infarct, stroke and heavy injuries, and
* Any other conditions not suitable for trial as evaluated by the physician.
20 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Science and Technology Council, Taiwan
OTHER_GOV
Taipei Hospital, Taiwan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Taipei Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Chung-Hua Hsu, MD; PhD
Role: STUDY_CHAIR
Branch of Chinese Medicine, Taipei City Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Branch of Chinese Medicine, Taipei City Hospital
Taipei, , Taiwan
Branch of Chinese Medicine
Taipei, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Kao YH, Chang HH, Lee MJ, Chen CL. Tea, obesity, and diabetes. Mol Nutr Food Res. 2006 Feb;50(2):188-210. doi: 10.1002/mnfr.200500109.
Hsu CH, Liao YL, Lin SC, Tsai TH, Huang CJ, Chou P. Does supplementation with green tea extract improve insulin resistance in obese type 2 diabetics? A randomized, double-blind, and placebo-controlled clinical trial. Altern Med Rev. 2011 Jun;16(2):157-63.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NSC-96-2320-13-192-001
Identifier Type: -
Identifier Source: secondary_id
Tpe-2007-IRB-05
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.